RTW vs. BHMG, ATT, MYI, N91, WWH, FEV, VEIL, PNL, WTAN, and BRW
Should you be buying RTW Biotech Opportunities stock or one of its competitors? The main competitors of RTW Biotech Opportunities include BH Macro GBP (BHMG), Allianz Technology Trust (ATT), Murray International (MYI), Ninety One Group (N91), Worldwide Healthcare (WWH), Fidelity European Trust (FEV), Vietnam Enterprise (VEIL), Personal Assets (PNL), Witan Investment Trust (WTAN), and Brewin Dolphin (BRW). These companies are all part of the "asset management" industry.
RTW Biotech Opportunities vs. Its Competitors
BH Macro GBP (LON:BHMG) and RTW Biotech Opportunities (LON:RTW) are both small-cap financial services companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, institutional ownership, media sentiment, risk, dividends, analyst recommendations, profitability and earnings.
RTW Biotech Opportunities has a net margin of 664.38% compared to BH Macro GBP's net margin of 150.73%. RTW Biotech Opportunities' return on equity of 25.18% beat BH Macro GBP's return on equity.
58.4% of BH Macro GBP shares are owned by institutional investors. Comparatively, 3.9% of RTW Biotech Opportunities shares are owned by institutional investors. 7.2% of BH Macro GBP shares are owned by insiders. Comparatively, 16.2% of RTW Biotech Opportunities shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
RTW Biotech Opportunities has higher revenue and earnings than BH Macro GBP. RTW Biotech Opportunities is trading at a lower price-to-earnings ratio than BH Macro GBP, indicating that it is currently the more affordable of the two stocks.
In the previous week, BH Macro GBP's average media sentiment score of 0.00 equaled RTW Biotech Opportunities'average media sentiment score.
BH Macro GBP has a beta of -0.28, suggesting that its share price is 128% less volatile than the S&P 500. Comparatively, RTW Biotech Opportunities has a beta of 0.6, suggesting that its share price is 40% less volatile than the S&P 500.
Summary
RTW Biotech Opportunities beats BH Macro GBP on 6 of the 11 factors compared between the two stocks.
Get RTW Biotech Opportunities News Delivered to You Automatically
Sign up to receive the latest news and ratings for RTW and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding RTW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
RTW Biotech Opportunities Competitors List
Related Companies and Tools
This page (LON:RTW) was last updated on 8/10/2025 by MarketBeat.com Staff
